Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP204512.RAz4sj6-4IupsJyVhJZtiUo15seQkKWjio5mva9dgsfCI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP204512.RAz4sj6-4IupsJyVhJZtiUo15seQkKWjio5mva9dgsfCI130_assertion type Assertion NP204512.RAz4sj6-4IupsJyVhJZtiUo15seQkKWjio5mva9dgsfCI130_head.
- NP204512.RAz4sj6-4IupsJyVhJZtiUo15seQkKWjio5mva9dgsfCI130_assertion description "[We found that an increased risk of CMM was associated with the FAS-1377GG [adjusted odds ratio (OR)=1.32; 95% confidence interval (CI)=1.00-1.75 for -1377GG] and -670AA (adjusted OR=1.28; 95% CI=1.00-1.65 for -670AA) genotypes compared to the -1377AA/AG and -670AG/GG genotypes, respectively; an increased risk of CMM was associated with the FASLG-IVS2nt-124AG+GG (OR=1.54; 95% CI=1.18-2.01) genotype compared to the AA genotype, but no evident risk was associated with any of the FAS-844T>C genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP204512.RAz4sj6-4IupsJyVhJZtiUo15seQkKWjio5mva9dgsfCI130_provenance.
- NP204512.RAz4sj6-4IupsJyVhJZtiUo15seQkKWjio5mva9dgsfCI130_assertion evidence source_evidence_literature NP204512.RAz4sj6-4IupsJyVhJZtiUo15seQkKWjio5mva9dgsfCI130_provenance.
- NP204512.RAz4sj6-4IupsJyVhJZtiUo15seQkKWjio5mva9dgsfCI130_assertion SIO_000772 16538172 NP204512.RAz4sj6-4IupsJyVhJZtiUo15seQkKWjio5mva9dgsfCI130_provenance.
- NP204512.RAz4sj6-4IupsJyVhJZtiUo15seQkKWjio5mva9dgsfCI130_assertion wasDerivedFrom befree-20140225 NP204512.RAz4sj6-4IupsJyVhJZtiUo15seQkKWjio5mva9dgsfCI130_provenance.
- NP204512.RAz4sj6-4IupsJyVhJZtiUo15seQkKWjio5mva9dgsfCI130_assertion wasGeneratedBy ECO_0000203 NP204512.RAz4sj6-4IupsJyVhJZtiUo15seQkKWjio5mva9dgsfCI130_provenance.